NCT07211360View on ClinicalTrials.gov

Integrated PET/MR Imaging With Amino Acid Radiotracers in the Evaluation of Brain Neoplasms: Assessing Diagnostic Accuracy and Therapeutic Response

Not yet recruitingOBSERVATIONAL

Enrollment

270

Participants

Timeline

Start Date

October 1, 2025

Primary Completion Date

September 30, 2028

Study Completion Date

September 30, 2031

Conditions

Primary and Secondary Brain Tumors

All Listed Sponsors

lead

IRCCS San Raffaele

OTHER

NCT07211360 - Integrated PET/MR Imaging With Amino Acid Radiotracers in the Evaluation of Brain Neoplasms: Assessing Diagnostic Accuracy and Therapeutic Response | Biotech Hunter | Biotech Hunter